Related Experiment Video

Updated: Jun 4, 2026

A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae
10:39

A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae

Published on: September 17, 2020

SirT1 brings stemness closer to cancer and aging

Vincenzo Calvanese1, Mario F Fraga

  • 1Department of Immunology and Oncology, Centro Nacional Biotecnología/CSIC, Cantoblanco, Madrid, Spain.

Aging
|February 11, 2011
PubMed

Insights

Sirtuin 1 (SirT1) regulates stem cell pluripotency and differentiation, impacting cancer therapy and anti-aging strategies. This study explores SirT1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Sirtuin 1 (SirT1) is known for its roles in cellular processes, including chromatin and protein deacetylation.
  • Its involvement in cancer and aging is extensively studied.
  • Emerging research highlights SirT1's function beyond these known roles.

Purpose of the Study:

  • To elucidate the role of Sirtuin 1 (SirT1) in regulating stem cell pluripotency and differentiation.
  • To explore the therapeutic implications of targeting SirT1 in cancer treatment.
  • To evaluate the potential of SirT1 activation in anti-aging therapies.

Main Methods:

  • Investigated SirT1's function in stem cell pluripotency using molecular and cellular assays.
  • Analyzed the impact of SirT1 modulation on stem cell differentiation pathways.
  • Correlated findings with existing data on sirtuin inhibition in cancer and activation for aging.

Main Results:

  • Sirtuin 1 (SirT1) demonstrates a significant role in maintaining stem cell pluripotency.
  • SirT1 activity influences key pathways governing stem cell differentiation.
  • Modulating SirT1 levels impacts cellular fate decisions relevant to aging and cancer.

Conclusions:

  • Sirtuin 1 (SirT1) is a critical regulator of stem cell pluripotency and differentiation.
  • Targeting SirT1 offers potential for novel cancer therapies via inhibition.
  • SirT1 activation presents a promising avenue for developing anti-aging interventions.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...